Azor

— THERAPEUTIC DISORDERS TREATED —
  • Hypertension

Azor Generic Name & Formulations

General Description

Amlodipine (as besylate), olmesartan medoxomil; 5mg/20mg, 10mg/20mg, 5mg/40mg, 10mg/40mg; tabs.

Pharmacological Class

Calcium channel blocker (CCB) + angiotensin II receptor blocker (ARB).

How Supplied

Tabs—30, 90, 100, 1000

Manufacturer

Generic Availability

NO

Azor Indications

Indications

Hypertension.

Azor Dosage and Administration

Adult

Individualize. Initially 5/20mg once daily; may increase after 1–2 weeks up to max 10/40mg daily. ≥75yrs or hepatic impairment: initial therapy not recommended.

Children

Not established.

Azor Contraindications

Contraindications

Concomitant aliskiren in patients with diabetes.

Azor Boxed Warnings

Boxed Warning

Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

Azor Warnings/Precautions

Warnings/Precautions

Fetal toxicity may develop; discontinue if pregnancy is detected. Volume/salt depleted. Severe obstructive coronary disease. Severe aortic stenosis. Severe hepatic or renal impairment. Renal artery stenosis. Consider discontinuing if sprue-like enteropathy develops and no other etiology is identified. Monitor electrolytes periodically. Elderly (may need lower initial dose of amlodipine). Neonates. Pregnancy: monitor. Nursing mothers: not recommended.

Azor Pharmacokinetics

See Literature

Azor Interactions

Interactions

See Contraindications. Potentiates simvastatin; limit simvastatin dose to 20mg/day. May potentiate cyclosporine, tacrolimus, lithium; monitor levels. Potentiated by CYP3A4 inhibitors; may need dose reduction. Antagonized by NSAIDs (including selective COX-2 inhibitors); may impair renal function (monitor). Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; monitor closely. Concomitant aliskiren in renal impairment (CrCl <60mL/min): not recommended. Consider taking at least 4hrs before colesevelam HCl dose. Monitor BP with CYP3A4 inducers.

Azor Adverse Reactions

Adverse Reactions

Edema, dizziness; headache, hypotension, rash, pruritus, palpitation, urinary frequency, nocturia, hepatic or renal dysfunction, decreased hematocrit, decreased hemoglobin, hyperkalemia (rare).

Azor Clinical Trials

See Literature

Azor Note

Not Applicable

Azor Patient Counseling

See Literature